J. Takagi, Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins, Biochemical Society Transactions, vol.32, issue.3, pp.403-406, 2004.
DOI : 10.1042/bst0320403

R. Hynes, Integrins: A family of cell surface receptors, Cell, vol.48, issue.4, pp.549-554, 1987.
DOI : 10.1016/0092-8674(87)90233-9

R. Hynes, Integrins: Versatility, modulation, and signaling in cell adhesion, Cell, vol.69, issue.1, pp.11-25, 1992.
DOI : 10.1016/0092-8674(92)90115-S

R. Haubner, R. Gratias, B. Diefenbach, S. Goodman, A. Jonczyck et al., Antagonists, Journal of the American Chemical Society, vol.118, issue.32, pp.7461-7472, 1996.
DOI : 10.1021/ja9603721

S. Stromblad and D. Cheresh, Integrins, angiogenesis and vascular cell survival, Chemistry & Biology, vol.3, issue.11, pp.881-885, 1996.
DOI : 10.1016/S1074-5521(96)90176-3

C. Gladson, Expression of Integrin ??????3 in Small Blood Vessels of Glioblastoma Tumors, Journal of Neuropathology & Experimental Neurology, vol.55, issue.11, pp.1143-1149, 1996.
DOI : 10.1097/00005072-199611000-00005

C. Gladson and D. Cheresh, Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells., Journal of Clinical Investigation, vol.88, issue.6, pp.1924-1932, 1991.
DOI : 10.1172/JCI115516

K. Gehlsen, G. Davis, and P. Sriramarao, Integrin expression in human melanoma cells with differing invasive and metastatic properties, Clinical & Experimental Metastasis, vol.109, issue.2, pp.111-120, 1992.
DOI : 10.1007/BF00114587

R. Seftor, E. Seftor, K. Gehlsen, W. Stetler-stevenson, P. Brown et al., Role of the alpha v beta 3 integrin in human melanoma cell invasion., Proceedings of the National Academy of Sciences, vol.89, issue.5, pp.1557-1561, 1992.
DOI : 10.1073/pnas.89.5.1557

E. Filardo, P. Brooks, S. Deming, C. Damsky, and D. Cheresh, Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo, The Journal of Cell Biology, vol.130, issue.2, pp.441-450, 1995.
DOI : 10.1083/jcb.130.2.441

S. Kwon, S. Ke, J. Houston, W. Wang, Q. Wu et al., Imaging dose-dependent pharmacokinetics of an RGD-fluorescent dye conjugate targeted to alpha v beta 3 receptor expressed in Kaposi's sarcoma, Mol Imaging, vol.4, issue.2, pp.75-87, 2005.

W. Wang, S. Ke, Q. Wu, C. Charnsangavej, M. Gurfinkel et al., Near-Infrared Optical Imaging of Integrin ??v??3 in Human Tumor Xenografts, Molecular Imaging, vol.3, issue.4, pp.343-351, 2004.
DOI : 10.1162/1535350042973481

X. Chen, P. Conti, and R. Moats, In vivo Near-Infrared Fluorescence Imaging of Integrin ??v??3 in Brain Tumor Xenografts, Cancer Research, vol.64, issue.21, pp.8009-8014, 2004.
DOI : 10.1158/0008-5472.CAN-04-1956

M. Gurfinkel, S. Ke, W. Wang, C. Li, and E. Sevick-muraca, Quantifying molecular specificity of ??v??3 integrin-targeted optical contrast agents with dynamic optical imaging, Journal of Biomedical Optics, vol.10, issue.3, p.34019, 2005.
DOI : 10.1117/1.1924696

Z. Cheng, Y. Wu, Z. Xiong, S. Gambhir, and X. Chen, Expression in Living Mice, Bioconjugate Chemistry, vol.16, issue.6, pp.1433-1441, 2005.
DOI : 10.1021/bc0501698

E. Garanger, D. Boturyn, J. Z. Dumy, P. Favrot, M. Coll et al., New Multifunctional Molecular Conjugate Vector for Targeting, Imaging, and Therapy of Tumors, Molecular Therapy, vol.12, issue.6, pp.1168-1175, 2005.
DOI : 10.1016/j.ymthe.2005.06.095

Z. Jin, V. Josserand, J. Razkin, E. Garanger, D. Boturyn et al., Non-invasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4, Mol Imaging, vol.5, issue.3, pp.188-197, 2006.

Y. Wu, X. Zhang, Z. Xiong, Z. Cheng, D. Fisher et al., Chen X: microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide, J Nucl Med, issue.10, pp.461707-1718, 2005.

D. Boturyn, J. Coll, E. Garanger, M. Favrot, and P. Dumy, Template Assembled Cyclopeptides as Multimeric System for Integrin Targeting and Endocytosis, Journal of the American Chemical Society, vol.126, issue.18, pp.5730-5739, 2004.
DOI : 10.1021/ja049926n

R. Weissleder, K. Kelly, E. Sun, T. Shtatland, and L. Josephson, Cell-specific targeting of nanoparticles by multivalent attachment of small molecules, Nature Biotechnology, vol.29, issue.11, pp.1418-1423, 2005.
DOI : 10.1093/bioinformatics/bth349

R. Shukla, T. Thomas, J. Peters, A. Kotlyar, A. Myc et al., Tumor angiogenic vasculature targeting with PAMAM dendrimer???RGD conjugates, Chemical Communications, vol.40, issue.5526, pp.5739-5741
DOI : 10.1039/b507350b

A. Schraa, R. Kok, H. Moorlag, E. Bos, J. Proost et al., Targeting of RGD-modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study, International Journal of Cancer, vol.99, issue.5, pp.469-475, 2002.
DOI : 10.1002/ijc.10727

R. Harbottle, R. Cooper, S. Hart, A. Ladhoff, T. Mckay et al., An RGD???Oligolysine Peptide: A Prototype Construct for Integrin-Mediated Gene Delivery, Human Gene Therapy, vol.9, issue.7, pp.1037-1047, 1998.
DOI : 10.1089/hum.1998.9.7-1037

D. Bibby, J. Talmadge, M. Dalal, S. Kurz, K. Chytil et al., Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice, International Journal of Pharmaceutics, vol.293, issue.1-2, pp.281-290, 2005.
DOI : 10.1016/j.ijpharm.2004.12.021

Y. Ye, S. Bloch, B. Xu, and S. Achilefu, Design, Synthesis, and Evaluation of Near Infrared Fluorescent Multimeric RGD Peptides for Targeting Tumors, Journal of Medicinal Chemistry, vol.49, issue.7, pp.2268-2275, 2006.
DOI : 10.1021/jm050947h

S. Liu, W. Hsieh, Y. Jiang, Y. Kim, S. Sreerama et al., -Positive Breast Cancer, Bioconjugate Chemistry, vol.18, issue.2, pp.438-446, 2007.
DOI : 10.1021/bc0603081
URL : https://hal.archives-ouvertes.fr/tel-00259428

R. Haubner, F. Bruchertseifer, M. Bock, H. Kessler, M. Schwaiger et al., Synthesis and biological evaluation of a (99m)Tc- labelled cyclic RGD peptide for imaging the alphavbeta3 expression, Nuklearmedizin, vol.43, issue.1, pp.26-32, 2004.

C. Li, W. Wang, Q. Wu, S. Ke, J. Houston et al., Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe, Nuclear Medicine and Biology, vol.33, issue.3, pp.349-358, 2006.
DOI : 10.1016/j.nucmedbio.2006.01.001

D. Cheresh and R. Spiro, Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor, J Biol Chem, issue.36, pp.26217703-17711, 1987.